Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Shares Sold by Retirement Systems of Alabama

Retirement Systems of Alabama reduced its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 1.5% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 112,812 shares of the company’s stock after selling 1,694 shares during the quarter. Retirement Systems of Alabama’s holdings in Acadia Healthcare were worth $7,153,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Blue Trust Inc. increased its stake in shares of Acadia Healthcare by 86.1% in the second quarter. Blue Trust Inc. now owns 536 shares of the company’s stock worth $36,000 after acquiring an additional 248 shares during the period. GAMMA Investing LLC lifted its holdings in shares of Acadia Healthcare by 57.1% in the 3rd quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock valued at $42,000 after buying an additional 241 shares during the period. Point72 Asia Singapore Pte. Ltd. acquired a new stake in Acadia Healthcare during the second quarter worth about $59,000. Covestor Ltd boosted its position in Acadia Healthcare by 834.4% in the 3rd quarter. Covestor Ltd now owns 1,140 shares of the company’s stock worth $72,000 after purchasing an additional 1,018 shares in the last quarter. Finally, DekaBank Deutsche Girozentrale acquired a new stake in shares of Acadia Healthcare during the 3rd quarter worth approximately $86,000.

Analysts Set New Price Targets

ACHC has been the subject of a number of recent analyst reports. StockNews.com cut shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Friday, November 22nd. Deutsche Bank Aktiengesellschaft upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating and upped their price objective for the stock from $45.00 to $75.00 in a research report on Thursday, December 12th. Royal Bank of Canada cut their target price on shares of Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating for the company in a research note on Monday, November 18th. KeyCorp began coverage on shares of Acadia Healthcare in a research note on Friday, October 11th. They set a “sector weight” rating on the stock. Finally, Barclays dropped their price target on Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating for the company in a research report on Friday, November 22nd. One analyst has rated the stock with a sell rating, three have given a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $75.44.

Acadia Healthcare Price Performance

Shares of ACHC opened at $39.64 on Wednesday. The firm has a fifty day moving average price of $44.78 and a 200 day moving average price of $61.40. The stock has a market cap of $3.68 billion, a PE ratio of 13.00, a price-to-earnings-growth ratio of 1.77 and a beta of 1.29. Acadia Healthcare Company, Inc. has a 1-year low of $36.50 and a 1-year high of $87.77. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The company had revenue of $815.60 million during the quarter, compared to analysts’ expectations of $819.42 million. During the same quarter in the previous year, the business earned $0.91 earnings per share. The firm’s revenue for the quarter was up 8.7% on a year-over-year basis. As a group, sell-side analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.